Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vsee Health (VSEE) Common Equity (2023 - 2025)

Vsee Health (VSEE) has disclosed Common Equity for 3 consecutive years, with -$5.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Common Equity fell 697.51% year-over-year to -$5.6 million, compared with a TTM value of -$5.6 million through Sep 2025, down 697.51%, and an annual FY2024 reading of -$18488.0, up 99.57% over the prior year.
  • Common Equity was -$5.6 million for Q3 2025 at Vsee Health, up from -$5.7 million in the prior quarter.
  • Across five years, Common Equity topped out at $53.1 million in Q2 2024 and bottomed at -$5.7 million in Q2 2025.
  • Average Common Equity over 3 years is $2.4 million, with a median of -$1.8 million recorded in 2023.
  • The sharpest move saw Common Equity surged 6089.4% in 2024, then plummeted 697.51% in 2025.
  • Year by year, Common Equity stood at -$4.3 million in 2023, then skyrocketed by 99.57% to -$18488.0 in 2024, then crashed by 30057.39% to -$5.6 million in 2025.
  • Business Quant data shows Common Equity for VSEE at -$5.6 million in Q3 2025, -$5.7 million in Q2 2025, and -$3.5 million in Q1 2025.